Quantitative analysis of silver stained nucleolar organiser regions: a reliable marker of cell proliferation and a promising prognostic parameter in tumour pathology

Por Trerè, D
Publicado em 1995

AgNOR quantification in tumour pathology: what is actually evaluated?

Por Trerè, D
Publicado em 1993

Proportionally constant quantitative transmission of nucleolin and protein B23 in cycling cancer cells

Por Sirri, V, Pession, A, Trerè, D, Montanaro, L, Derenzini, M
Publicado em 1995

The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status

Por Derenzini, M, Ceccarelli, C, Santini, D, Taffurelli, M, Treré, D
Publicado em 2004

Relationship between interphasic nucleolar organizer regions and growth rate in two neuroblastoma cell lines.

Por Derenzini, M., Pession, A., Farabegoli, F., Trerè, D., Badiali, M., Dehan, P.
Publicado em 1989

AgNOR quantity in needle biopsy specimens of prostatic adenocarcinomas: correlation with proliferation state, Gleason score, clinical stage, and DNA content

Por Trerè, D, Zilbering, A, Dittus, D, Kim, P, Ginsberg, P C, Daskal, I
Publicado em 1996

Nucleolar function and size in cancer cells.

Por Derenzini, M., Trerè, D., Pession, A., Montanaro, L., Sirri, V., Ochs, R. L.
Publicado em 1998

Relation between deletion of chromosome 1p36 and DNA ploidy in breast carcinoma: an interphase cytogenetic study

Por Farabegoli, F, Baldini, N, Santini, D, Ceccarelli, C, Taffurelli, M, Treré, D, Derenzini, M
Publicado em 1996

Progression on metastatic neuroendocrine carcinoma from a recurrent prolactinoma: a case report

Por Sironi, M, Cenacchi, G, Cozzi, L, Tonnarelli, G, Iacobellis, M, Treré, D, Assi, A
Publicado em 2002

Prognostic relevance of pretreatment proliferative rapidity of marrow blast cells in childhood acute lymphoblastic leukaemia.

Por Trerè, D., Pession, A., Basso, G., Rondelli, R., Masera, G., Paolucci, G., Derenzini, M.
Publicado em 1994

Is high AgNOR quantity in hepatocytes associated with increased risk of hepatocellular carcinoma in chronic liver disease?

Por Derenzini, M, Trerè, D, Oliveri, F, David, E, Colombatto, P, Bonino, F, Brunetto, M R
Publicado em 1993

Erosions or not in GORD? The potential role of oesophageal cell proliferation

Por Calabrese, C, Cenacchi, G, Trerè, D, Fabbri, A, Derenzini, M, Miglioli, M, Di Febo, G
Publicado em 2005

Imbalance of IL-1β and IL-1 receptor antagonist mRNA in liver tissue from hepatitis C virus (HCV)-related chronic hepatitis

Por Gramantieri, L, Casali, A, Trerè, D, Gaiani, S, Piscaglia, F, Chieco, P, Cola, B, Bolondi, L
Publicado em 1999

The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells

Por Trerè, D, Fiume, L, Giorgi, L Badiali De, Stefano, G Di, Migaldi, M, Derenzini, M
Publicado em 1999

Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer

Por Brighenti, E, Calabrese, C, Liguori, G, Giannone, F A, Trerè, D, Montanaro, L, Derenzini, M
Publicado em 2014

Thymidylate synthase protein expression and activity are related to the cell proliferation rate in human cancer cell lines

Por Derenzini, M, Montanaro, L, Treré, D, Chillà, A, Tazzari, P L, Dall’Olio, F, Öfner, D
Publicado em 2002

Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis.

Por Borzio, M, Trerè, D, Borzio, F, Ferrari, A R, Bruno, S, Roncalli, M, Colloredo, G, Leandro, G, Oliveri, F, Derenzini, M
Publicado em 1998